Showing posts with label rociletinib therapy in patients with EGFR mutant-positive NSCLC. Show all posts
Showing posts with label rociletinib therapy in patients with EGFR mutant-positive NSCLC. Show all posts
Tuesday, March 1, 2016

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

›
Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an in...